FTC Suing To Stop Amgen’s $27.8 Billion Purchase Of Horizon Therapeutics

FTC Suing To Stop Amgen’s $27.8 Billion Purchase Of Horizon Therapeutics

The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.

Author picture

You may also like

Hot News

TRENDING NEWS

SUBCRIBE

Lorem ipsum dolor sit amet con sectetur adipiscing

follow us

Photo

Discover more from entrepreneurs.news

Subscribe now to keep reading and get access to the full archive.

Continue reading